BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 31607310)

  • 1. [Effect of ABCG2 on Side Population Cells and Related Pathways in Multiple Myeloma].
    Wang L; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1548-1555. PubMed ID: 31607310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma.
    Wang L; Lin N; Li Y
    Oncol Rep; 2019 Mar; 41(3):1678-1690. PubMed ID: 30664164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia.
    Huang FF; Zhang L; Wu DS; Yuan XY; Yu YH; Zhao XL; Chen FP; Zeng H
    PLoS One; 2014; 9(3):e88298. PubMed ID: 24603487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
    Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H
    Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.
    Bleau AM; Hambardzumyan D; Ozawa T; Fomchenko EI; Huse JT; Brennan CW; Holland EC
    Cell Stem Cell; 2009 Mar; 4(3):226-35. PubMed ID: 19265662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma.
    Du J; Liu S; He J; Liu X; Qu Y; Yan W; Fan J; Li R; Xi H; Fu W; Zhang C; Yang J; Hou J
    Oncotarget; 2015 Jun; 6(17):14993-5007. PubMed ID: 25915427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway.
    Chen M; Lu X; Lu C; Shen N; Jiang Y; Chen M; Wu H
    Arthritis Res Ther; 2018 Feb; 20(1):20. PubMed ID: 29415757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy.
    Fischer B; Frei C; Moura U; Stahel R; Felley-Bosco E
    Lung Cancer; 2012 Oct; 78(1):23-9. PubMed ID: 22857894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
    Pick A; Wiese M
    ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.
    Hu C; Li H; Li J; Zhu Z; Yin S; Hao X; Yao M; Zheng S; Gu J
    Carcinogenesis; 2008 Dec; 29(12):2289-97. PubMed ID: 18820285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
    Kim KH; Cheong HJ; Lee MY; Lee N; Lee KT; Park SK; Won JH
    Anticancer Res; 2019 Jan; 39(1):127-133. PubMed ID: 30591449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
    Kim RJ; Bae E; Hong YK; Hong JY; Kim NK; Ahn HJ; Oh JJ; Park DS
    Oncology; 2014; 87(5):270-9. PubMed ID: 25139413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scutellaria extract decreases the proportion of side population cells in a myeloma cell line by down-regulating the expression of ABCG2 protein.
    Lin MG; Liu LP; Li CY; Zhang M; Chen Y; Qin J; Gu YY; Li Z; Wu XL; Mo SL
    Asian Pac J Cancer Prev; 2013; 14(12):7179-86. PubMed ID: 24460272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
    Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
    [No Abstract]   [Full Text] [Related]  

  • 17. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells.
    Goler-Baron V; Sladkevich I; Assaraf YG
    Biochem Pharmacol; 2012 May; 83(10):1340-8. PubMed ID: 22342288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
    Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
    Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.